InfuSystem Holdings (INFU): Market Capitalization-to-Revenue Ratio

Symbol and logo of brand InfuSystem Holdings (INFU)

High FDA regulatory barriers and long-term equipment leases protect the position of InfuSystem Holdings. The current P/S ratio confirms this resilience, and the value of 2.00 shows the latest metric reading. Revenues are based on the supply of infusion pumps to clinics. A stable cash flow from maintenance services and consumables provides the company with a real financial impact today.

Price-to-Revenue Ratio: InfuSystem (INFU) for 07/04/2022 - 11/13/2026

Metric breakdowns and analytics for InfuSystem Holdings (INFU)

- stock quotes and analyst forecast:
Price infusystem.com|INFU - Price Target Chart
- stock exchange capitalization data:
Market Value InfuSystem Inc|INFU - Real Price to Acquire Entire Company
- book capitalization indicators:
Book Value per Share InfuSystem Holdings|INFU - Company Book Value|Market Cap to Net Assets Ratio infusystem.com|INFU - Company Total Assets
- business debt structure and liquidity details:
Debt to Capital InfuSystem Holdings|INFU - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio infusystem.com|INFU - Company Total Debt|Debt to Book Capital InfuSystem Inc|INFU - Company Long-Term Debt|Short-Term Debt Volume InfuSystem Holdings|Interim Coverage Ratio infusystem.com
- company profitability and valuation multiples indicators:
INFU - Company Net Income|Net Profit Forecast InfuSystem Holdings|INFU - P/E Multiple|Price to Expected Earnings Ratio infusystem.com|INFU - Price/Earnings to Growth Multiple|EV/EBITDA Multiple InfuSystem Inc|INFU - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters InfuSystem Holdings|INFU - Net earnings per share for the last 12 months|Earnings per share growth in annualized terms for the last twelve months infusystem.com|INFU - Earnings per share growth in current year|Consensus forecast of earnings per share growth for next year InfuSystem Holdings
- total revenue and sales volume data:
INFU - Company Sales|Company Projected Revenue Volume infusystem.com|INFU - P/S Multiple|Market Cap to Future Revenue Ratio InfuSystem Inc
Summary company analytics:InfuSystem
Mass-produced product of InfuSystem

The ratio of InfuSystem Holdings (INFU) market capitalization to its annual revenue allows for an assessment of whether the quotes are fair relative to the actual earnings of the independent clinical service network. By analyzing historical P/S levels, an investor can determine how effectively the market values the company's autonomy from vendors, where an inflated metric amid stagnating sales signals a risk of price correction.

Competitors of InfuSystem Holdings

Market Cap to Sales Volume ISRG|Price-to-Revenue Ratio Danaher DHR|Market Capitalization-to-Revenue Ratio BDX|STE: Market Cap to Revenue|WST - P/S Multiple|Baxter International (BAX) - Price-to-Revenue Ratio|Market Cap to Revenue masimo.com|STVN (Stevanato Group) - P/S Multiple|Price to Sales Teleflex Inc. TFX|Price-to-Revenue Ratio Merit Medical Systems Inc (MMSI)|Nobel Biocare - Market Cap to Revenue Ratio|ICU Medical, Inc. - Market Cap to Revenue|Market Cap to Sales Volume XRAY (dentsplysirona.com)|LMAT - Price-to-Revenue Ratio|Price-to-Revenue Coefficient AtriCure Inc ATRC|STAA: P/S Multiple|NAGE - Price-to-Revenue Coefficient|Price-to-Revenue Ratio ZimVie Inc.|Market Cap to Revenue Ratio ANGO (angiodynamics.com)|P/S Multiple CERS|TKNO: Price-to-Sales Ratio|Monogram Technologies Inc - Market Cap to Revenue|P/S Multiple Sharps Technology Inc STSS|UTMD - Price-to-Revenue Ratio|Price-to-Revenue Coefficient KORU Medical Systems KRMD|NYXH (Nyxoah) - Market Cap to Revenue|Price to Sales Microbot Medical, Inc. (MBOT)|Price-to-Revenue Ratio Pro-Dex Corp|Zentek Corp (ZTEK) - Price-to-Revenue Coefficient|Market Cap to Revenue ELUT (Elutia Inc.)|Market Cap to Sales Volume MLSS|P/S Multiple NXGL (NEXGEL)|Retractable Technologies Inc. (RVP) - Price to Sales|HBIO - Price-to-Revenue Ratio|Femasys Corporation (FEMY) - Market Cap to Revenue|MHUA (meihuamed.com) - Market Cap to Revenue|Predictive Oncology Inc. - Market Capitalization-to-Revenue Ratio|CJMB (Callan JMB Inc.) - P/S Multiple|ATRI: Market Capitalization-to-Revenue Ratio|Price-to-Revenue Ratio NeuroMetrix Corp (NURO)